- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Absci Corp (ABSI)
Absci Corp stock price live, this page displays NASDAQ ABSI stock exchange data. View the ABSI premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Absci Corp real time stock price chart below.
What Is the Absci Corp Stock Price Today?
The Absci Corp stock price today is 9,690.
What Is the Stock Symbol for Absci Corp?
The stock symbol for Absci Corp is "ABSI."
What Stock Exchange Does Absci Corp Trade On?
Absci Corp is listed and trades on the NASDAQ stock exchange.
Is Absci Corp a Good Stock to Buy?
Determining whether Absci Corp—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the ABSI quote. (ISIN: US00091E1091)
What Is the Absci Corp Stock Price Today?
The Absci Corp stock price today is 9,690.
What Is the Stock Symbol for Absci Corp?
The stock symbol for Absci Corp is "ABSI."
What Stock Exchange Does Absci Corp Trade On?
Absci Corp is listed and trades on the NASDAQ stock exchange.
Is Absci Corp a Good Stock to Buy?
Determining whether Absci Corp—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the ABSI quote. (ISIN: US00091E1091)
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
9.680
11.320
52 wk Range
2.240
12.545
Earnings results expected in 9 days
1/2
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
9.68011.320
52 wk Range
2.24012.545
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
ABSI Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceAnalysts Sentiment
Strong Buy
Price Target
14.818
Upside
+52.92%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
4 analysts have revised their earnings downwards for the upcoming period
Absci receives Investment Bank Analyst Rating Update- Investing.com
Pro
Absci Corp stock hits 52-week high at 12.06 USD- Investing.com
- Absci Corp stock hits 52-week high at 12.06 USD
- Investing.com
Absci receives Investment Bank Analyst Rating Update- Investing.com
Pro
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Analyst Ratings
11 Buy
1 Hold
0 Sell
Ratings:
12 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 14.818
(+52.92% Upside)
Absci Corp Earnings Call Summary for Q2/2026
- Absci posted Q2 loss of $0.21/share vs. $0.19 expected; revenue of $300K missed $1.01M forecast by 70.3%, sending shares down 17.43% after-hours.
- Cash position rose to $201.1M from $125.7M, bolstered by $93.6M stock offering and $40M Eli Lilly investment; runway extended into H2 2028.
- Lead candidate ABS-201 showed favorable interim safety data; 13-week HEADLINE trial results expected H2 2026, full 26-week data due early 2027.
- Phase II endometriosis trial planned for Q4 2026 with proof-of-concept data anticipated H2 2027; management estimates $25B+ U.S. market opportunity.
- R&D expenses climbed 10.2% to $22.6M; company plans to develop ABS-201 internally while evaluating partnership options for future pipeline programs.
Last Updated: 2026/08/11, 23:22
Read Full TranscriptEarnings
Latest Release
Aug 11, 2026
EPS / Forecast
-0,21 / -0,19
Revenue / Forecast
300K / 1,01M
Compare ABSI to Peers and Sector
Metrics to compare | ABSI | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipABSIPeersSector | |
|---|---|---|---|---|
P/E Ratio | −13.7x | −3.0x | −0.2x | |
PEG Ratio | −0.91 | −0.08 | 0.00 | |
Price/Book | 6.8x | 3.1x | 2.6x | |
Price / LTM Sales | 1,065.3x | 85.5x | 2.8x | |
Upside (Analyst Target) | 52.9% | 75.3% | 65.5% | |
Fair Value Upside | Unlock | 14.1% | 8.9% | Unlock |
Absci Corporation, a clinical-stage biopharmaceutical company, develops various antibody therapeutics in the United States. Its preclinical development programs include ABS-101, which is in Phase 1 clinical trial for the treatment of inflammatory bowel disease; ABS-201, an anti-prolactin receptor (PRLR) antibody, which is phase 1/2a clinical trial for treating androgenic alopecia; ABS-301 for the treatment of immuno-oncology; and ABS-501 for treating oncology. Absci Corporation has collaboration agreements with PrecisionLife, Memorial Sloan Kettering Cancer Center, Twist Bioscience, Owkin, Oracle Corporation, and Advanced Micro Devices, Inc. for joint research and development activities. The company was founded in 2011 and is headquartered in Vancouver, Washington.
Ownership
Ownership Overview
Top Holders
FAQ
What Is the Absci (ABSI) Stock Price Today?
The Absci stock price today is 9,690 USD.
What Stock Exchange Does Absci Trade On?
Absci is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for Absci?
The stock symbol for Absci is "ABSI."
What Is the Absci Market Cap?
As of today, Absci market cap is 1,660B USD.
What Is Absci's Earnings Per Share (TTM)?
The Absci EPS (TTM) is -0,80.
When Is the Next Absci Earnings Date?
Absci will release its next earnings report on Nov 12, 2026.
From a Technical Analysis Perspective, Is ABSI a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Buy.
How Many Times Has Absci Stock Split?
Absci has split 0 times.
How Many Employees Does Absci Have?
Absci has 140 employees.
What is the current trading status of Absci (ABSI)?
As of Nov 03, 2026, Absci (ABSI) is trading at a price of 9,690 USD, with a previous close of 9,690 USD. The stock has fluctuated within a day range of 9,680 USD to 11,320 USD, while its 52-week range spans from 2,240 USD to 12,545 USD.
What Is Absci (ABSI) Price Target According to Analysts?
The average 12-month price target for Absci is 14,818 USD, with a high estimate of 20 USD and a low estimate of 10 USD. 11 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +52,92% Upside potential.
What Is the ABSI Premarket Price?
ABSI's last pre-market stock price is 10,099 USD. The pre-market share volume is 25 040,000, and the stock has decreased by 0,409, or 4,220%.
What Is the ABSI After Hours Price?
ABSI's last after hours stock price is 9,740 USD, the stock has decreased by 0,050, or 0,520%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.